The dynamic balance and plasticity between these two subsets, particularly their bidirectional interconversion mediated by TGF-β, IL-6, and IL-1β, critically shape the immune landscape of NSCLC. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.